404
Oxygen Therapy Device Market Analysis | 2023-2028
Oxygen Therapy Device Market Size, Share, Trends, Dynamics, Forecast, & Growth Analysis: 2023-2028
Oxygen therapy device is designed to provide oxygen to people who are not able to get oxygen on their own due to the prevalence of various diseases such as pneumonia, chronic obstructive pulmonary disease (COPD), bronchopulmonary dysplasia (underdeveloped lungs in new-borns), sleep apnea, asthma, heart failure, cystic fibrosis, and lung disease among others.
The oxygen therapy device market was estimated at USD 35.29 billion in 2022.
The oxygen therapy device market is likely to reach USD 49.44 billion in 2028.
The oxygen therapy device market is likely to grow at a CAGR of 5.74% during 2023-2028.
Koninklijke Philips N.V. (Netherlands), Becton, Dickinson and Company (The U.S.), Linde Group (Ireland), Smiths Group PLC (UK), Taiyo Nippon Sanso Corporation (Japan), Teleflex Incorporated (The U.S.), Drägerwerk AG & Co. KGaA (Germany), Invacare Corporation (The U.S.), Fisher & Paykel Healthcare Corporation Limited (New Zealand), Chart Industries, Inc. (The U.S.), and Inogen, Inc. (The U.S.) are among the key players in the oxygen therapy devices market.
North America accounted for the largest share of oxygen therapy device market in 2022.
Oxygen source equipment segment accounted for the largest market share in 2022 & is the leading segment by product type.
The major factors driving the growth of the oxygen therapy device market are the increasing use of oxygen therapy devices for people suffering from chronic lung-related diseases & growing emphasis on the development of cost-effective and rapid oxygen therapy devices is witnessed to create lucrative opportunities for the players in the global market.